532 related articles for article (PubMed ID: 19659774)
1. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals.
Rosignoli G; Lim CH; Bower M; Gotch F; Imami N
Clin Exp Immunol; 2009 Jul; 157(1):90-7. PubMed ID: 19659774
[TBL] [Abstract][Full Text] [Related]
2. Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients.
Rosignoli G; Cranage A; Burton C; Nelson M; Steel A; Gazzard B; Gotch F; Imami N
AIDS; 2007 Jun; 21(10):1379-81. PubMed ID: 17545722
[TBL] [Abstract][Full Text] [Related]
3. Responsiveness of HIV-specific CD4 T cells to PD-1 blockade.
Porichis F; Kwon DS; Zupkosky J; Tighe DP; McMullen A; Brockman MA; Pavlik DF; Rodriguez-Garcia M; Pereyra F; Freeman GJ; Kavanagh DG; Kaufmann DE
Blood; 2011 Jul; 118(4):965-74. PubMed ID: 21652684
[TBL] [Abstract][Full Text] [Related]
4. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
Pettersen FO; Taskén K; Kvale D
Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
[TBL] [Abstract][Full Text] [Related]
5. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
D'Souza M; Fontenot AP; Mack DG; Lozupone C; Dillon S; Meditz A; Wilson CC; Connick E; Palmer BE
J Immunol; 2007 Aug; 179(3):1979-87. PubMed ID: 17641065
[TBL] [Abstract][Full Text] [Related]
6. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
Day CL; Kaufmann DE; Kiepiela P; Brown JA; Moodley ES; Reddy S; Mackey EW; Miller JD; Leslie AJ; DePierres C; Mncube Z; Duraiswamy J; Zhu B; Eichbaum Q; Altfeld M; Wherry EJ; Coovadia HM; Goulder PJ; Klenerman P; Ahmed R; Freeman GJ; Walker BD
Nature; 2006 Sep; 443(7109):350-4. PubMed ID: 16921384
[TBL] [Abstract][Full Text] [Related]
7. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy?
Lee S; Hammond T; Watson MW; Flexman JP; Cheng W; Fernandez S; Price P
Clin Exp Immunol; 2010 Jul; 161(1):118-26. PubMed ID: 20408862
[TBL] [Abstract][Full Text] [Related]
8. Skewed maturation of memory HIV-specific CD8 T lymphocytes.
Champagne P; Ogg GS; King AS; Knabenhans C; Ellefsen K; Nobile M; Appay V; Rizzardi GP; Fleury S; Lipp M; Förster R; Rowland-Jones S; Sékaly RP; McMichael AJ; Pantaleo G
Nature; 2001 Mar; 410(6824):106-11. PubMed ID: 11242051
[TBL] [Abstract][Full Text] [Related]
9. Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.
Porichis F; Hart MG; Zupkosky J; Barblu L; Kwon DS; McMullen A; Brennan T; Ahmed R; Freeman GJ; Kavanagh DG; Kaufmann DE
J Virol; 2014 Mar; 88(5):2508-18. PubMed ID: 24352453
[TBL] [Abstract][Full Text] [Related]
10. Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells.
Killian MS; Johnson C; Teque F; Fujimura S; Levy JA
J Virol; 2011 Feb; 85(4):1696-705. PubMed ID: 21147929
[TBL] [Abstract][Full Text] [Related]
11. Identification of PD-1 as a unique marker for failing immune reconstitution in HIV-1-infected patients on treatment.
Grabmeier-Pfistershammer K; Steinberger P; Rieger A; Leitner J; Kohrgruber N
J Acquir Immune Defic Syndr; 2011 Feb; 56(2):118-24. PubMed ID: 20980914
[TBL] [Abstract][Full Text] [Related]
12. HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells.
Muthumani K; Shedlock DJ; Choo DK; Fagone P; Kawalekar OU; Goodman J; Bian CB; Ramanathan AA; Atman P; Tebas P; Chattergoon MA; Choo AY; Weiner DB
J Immunol; 2011 Sep; 187(6):2932-43. PubMed ID: 21856939
[TBL] [Abstract][Full Text] [Related]
13. Prediction of PD-L1 inhibition effects for HIV-infected individuals.
Zheltkova V; Argilaguet J; Peligero C; Bocharov G; Meyerhans A
PLoS Comput Biol; 2019 Nov; 15(11):e1007401. PubMed ID: 31693657
[TBL] [Abstract][Full Text] [Related]
14. Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.
Resino S; Abad ML; Navarro J; Bellón JM; Sánchez-Ramón S; Angeles Muñoz-Fernández M
Clin Exp Immunol; 2003 Jan; 131(1):130-7. PubMed ID: 12519396
[TBL] [Abstract][Full Text] [Related]
15. Reversal of the CD8
Li J; Huang HH; Tu B; Zhou MJ; Hu W; Fu YL; Li XY; Yang T; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Zhen C; Shi M; Wang FS; Zhang C
Front Immunol; 2021; 12():687296. PubMed ID: 34177939
[TBL] [Abstract][Full Text] [Related]
16. siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals.
Breton G; Yassine-Diab B; Cohn L; Boulassel MR; Routy JP; Sékaly RP; Steinman RM
J Clin Immunol; 2009 Sep; 29(5):637-45. PubMed ID: 19562472
[TBL] [Abstract][Full Text] [Related]
17. Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4+ and CD8+ T cell subsets.
Mercier F; Boulassel MR; Yassine-Diab B; Tremblay C; Bernard NF; Sekaly RP; Routy JP
Clin Exp Immunol; 2008 Apr; 152(1):72-80. PubMed ID: 18279439
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point.
Northfield JW; Loo CP; Barbour JD; Spotts G; Hecht FM; Klenerman P; Nixon DF; Michaëlsson J
J Virol; 2007 Jun; 81(11):5759-65. PubMed ID: 17376902
[TBL] [Abstract][Full Text] [Related]
19. The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.
Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S
Haematologica; 2013 Jun; 98(6):953-63. PubMed ID: 23300177
[TBL] [Abstract][Full Text] [Related]
20. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
